SMARCA4 has been found to be a unique factor in medium to long-term (but not short-term) tumor cell survival in alveolar rhabdomyosarcoma (ARMS), and ACBI-1 shows similar long-term tumor cell dependence in vitro and in vivo (137). This evidence concerns the gene SMARCA4 and alveolar rhabdomyosarcoma.